BIDU-SW
09888
JD HEALTH
06618
ALI HEALTH
00241
NTES-S
09999
JD-SW
09618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 12.29%12.1B | ---- | 14.85%10.78B | ---- | 13.84%9.39B | ---- | 13.18%8.24B | ---- | 17.39%7.28B |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 7.05%-297.96M | ---- | 13.26%-320.56M | ---- | 7.59%-369.55M | ---- | 9.94%-399.9M | ---- | -70.30%-444.04M |
Dividend (income)- adjustment | ---- | -197.02%-21.45M | ---- | 93.41%-7.22M | ---- | -209.59%-109.55M | ---- | -13.58%-35.38M | ---- | -14.80%-31.15M |
Attributable subsidiary (profit) loss | ---- | -55.06%-944.51M | ---- | 47.13%-609.13M | ---- | 55.37%-1.15B | ---- | -88.05%-2.58B | ---- | -31.04%-1.37B |
Impairment and provisions: | ---- | 521.76%234.38M | ---- | 714.86%37.7M | ---- | ---6.13M | ---- | ---- | ---- | -99.89%914K |
-Impairment of trade receivables (reversal) | ---- | 146.83%93.05M | ---- | 714.86%37.7M | ---- | ---6.13M | ---- | ---- | ---- | ---- |
-Other impairments and provisions | ---- | --141.34M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.89%914K |
Revaluation surplus: | ---- | 44.84%-426.92M | ---- | -58.70%-774.01M | ---- | -361.79%-487.72M | ---- | --186.3M | ---- | ---- |
-Fair value of investment properties (increase) | ---- | 44.84%-426.92M | ---- | -58.70%-774.01M | ---- | -361.79%-487.72M | ---- | --186.3M | ---- | ---- |
Asset sale loss (gain): | ---- | 92.54%-23.51M | ---- | -665.91%-315.17M | ---- | 92.85%-41.15M | ---- | -2,700.49%-575.28M | ---- | -2,526.85%-20.54M |
-Loss (gain) from sale of subsidiary company | ---- | 72.15%-33.14M | ---- | -352.10%-119.01M | ---- | ---26.32M | ---- | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | -3.35%-5.24M | ---- | 65.80%-5.07M | ---- | -182.85%-14.83M | ---- | 42.64%-5.24M | ---- | -1,265.92%-9.14M |
-Loss (gain) from selling other assets | ---- | 107.78%14.87M | ---- | ---191.1M | ---- | ---- | ---- | -4,898.55%-570.04M | ---- | -9,992.04%-11.4M |
Depreciation and amortization: | ---- | 24.14%853.71M | ---- | 1.57%687.69M | ---- | 62.94%677.07M | ---- | -13.60%415.52M | ---- | 25.88%480.93M |
-Amortization of intangible assets | ---- | -3.69%179.1M | ---- | -3.63%185.96M | ---- | -11.69%192.95M | ---- | -24.05%218.48M | ---- | 25.22%287.66M |
Financial expense | ---- | 7.12%3.2B | ---- | 12.11%2.99B | ---- | -0.44%2.67B | ---- | 17.60%2.68B | ---- | 27.91%2.28B |
Exchange Loss (gain) | ---- | ---- | ---- | -99.97%31K | ---- | -23.66%123.13M | ---- | 256.38%161.28M | ---- | 248.83%45.26M |
Special items | ---- | -80.75%6.57M | ---- | -23.38%34.13M | ---- | 120.95%44.54M | ---- | --20.16M | ---- | ---- |
Operating profit before the change of operating capital | ---- | 17.47%14.69B | ---- | 16.51%12.5B | ---- | 32.24%10.73B | ---- | -1.29%8.12B | ---- | 5.15%8.22B |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 122.57%55.31M | ---- | -565.63%-245.05M | ---- | 140.29%52.63M | ---- | -843.38%-130.63M | ---- | 126.56%17.57M |
Developing property (increase)decrease | ---- | -20.78%-3.43B | ---- | -61.67%-2.84B | ---- | 10.25%-1.76B | ---- | -468.13%-1.96B | ---- | 134.34%532.03M |
Accounts receivable (increase)decrease | ---- | -16.20%-16.24B | ---- | 16.90%-13.97B | ---- | -14.44%-16.81B | ---- | -8.30%-14.69B | ---- | 16.37%-13.57B |
Accounts payable increase (decrease) | ---- | -47.84%6.88B | ---- | 57.58%13.19B | ---- | 68.18%8.37B | ---- | -38.56%4.98B | ---- | 69.07%8.1B |
Advance payment increase (decrease) | ---- | 60.28%-3.32M | ---- | -658.84%-8.35M | ---- | -94.46%1.49M | ---- | 496.64%26.97M | ---- | 100.37%4.52M |
prepayments (increase)decrease | ---- | -151.62%-108.15M | ---- | -53.11%209.49M | ---- | 145.31%446.75M | ---- | -316.57%-986.05M | ---- | -981.72%-236.71M |
Special items for working capital changes | ---- | 107.53%494.67M | ---- | -2,593.08%-6.57B | ---- | -84.44%263.41M | ---- | 132.24%1.69B | ---- | -198.93%-5.25B |
Cash from business operations | ---- | 2.98%2.34B | ---- | 75.08%2.27B | ---- | 143.93%1.3B | ---- | -35.91%-2.95B | ---- | -95.13%-2.17B |
Other taxs | ---- | 10.74%-1.84B | ---- | -11.39%-2.06B | ---- | -17.18%-1.85B | ---- | -197.10%-1.58B | ---- | 34.50%-531.1M |
Special items of business | -98.81%2M | ---- | 64.78%167.55M | ---- | 110.47%101.68M | ---- | 80.69%-971.27M | ---- | -257.83%-5.03B | ---- |
Net cash from operations | -98.81%2M | 136.19%500.99M | 64.78%167.55M | 138.46%212.12M | 110.47%101.68M | 87.83%-551.49M | 80.69%-971.27M | -67.57%-4.53B | -257.83%-5.03B | -40.52%-2.7B |
Cash flow from investment activities | ||||||||||
Interest received - investment | 23.83%159.43M | 17.63%283.78M | 15.68%128.75M | -16.05%241.25M | -9.70%111.3M | 3.92%287.38M | -21.70%123.26M | 10.92%276.55M | 22.28%157.42M | 65.16%249.32M |
Dividend received - investment | -16.82%333.22M | -24.54%639.95M | -21.08%400.61M | 12.31%848.03M | 8.56%507.63M | -55.86%755.11M | 59.09%467.59M | -20.16%1.71B | -78.76%293.91M | 226.91%2.14B |
Loan receivable (increase) decrease | 421.62%298.35M | -138.90%-124.81M | -144.21%-92.76M | --320.84M | --209.81M | ---- | ---- | -107.97%-54.6M | -98.69%8.95M | 136.32%685.13M |
Decrease in deposits (increase) | ---- | 197.02%308.07M | ---- | -1,353.18%-317.55M | ---- | -7.04%-21.85M | ---- | 6.13%-20.41M | ---- | -204.43%-21.75M |
Sale of fixed assets | ---- | 78.56%52.59M | ---- | -39.22%29.46M | ---- | 259.71%48.46M | ---- | -8.48%13.47M | ---- | -84.29%14.72M |
Purchase of fixed assets | -163.40%-398.64M | -55.01%-562.48M | 10.37%-151.34M | 47.14%-362.86M | 39.11%-168.86M | -25.17%-686.41M | -52.41%-277.29M | -9.07%-548.38M | 54.95%-181.94M | 37.61%-502.78M |
Purchase of intangible assets | ---- | ---2.94M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Sale of subsidiaries | --252.22M | -74.82%499.13M | ---- | 2,090.74%1.98B | --1.61B | -93.34%90.5M | ---- | --1.36B | ---- | ---- |
Recovery of cash from investments | ---- | -66.59%46.94M | ---- | 1,299.75%140.51M | ---- | --10.04M | ---- | ---- | ---- | 658.48%298.76M |
Cash on investment | -308.32%-1.08B | -34.49%134.01M | 122.13%516.53M | 104.94%204.56M | 113.38%232.54M | -110.51%-4.14B | -14.76%-1.74B | 56.14%-1.97B | -260.29%-1.51B | -40.30%-4.49B |
Other items in the investment business | -492.06%-1.16B | 96.11%-100.66M | 148.45%294.78M | -102.48%-2.59B | 23.90%-608.48M | -187.88%-1.28B | -451.19%-799.54M | 69.77%-443.65M | 93.77%-145.06M | -20.01%-1.47B |
Net cash from investment operations | -244.74%-1.59B | 134.32%1.17B | -42.25%1.1B | 110.14%500.84M | 185.37%1.9B | -1,621.42%-4.94B | -61.02%-2.22B | 110.50%324.54M | -44.65%-1.38B | 55.56%-3.09B |
Net cash before financing | -225.40%-1.59B | 134.88%1.67B | -36.81%1.26B | 112.99%712.96M | 162.60%2B | -30.47%-5.49B | 50.16%-3.2B | 27.39%-4.21B | -171.59%-6.41B | 34.74%-5.79B |
Cash flow from financing activities | ||||||||||
New borrowing | 2.74%18.23B | 29.58%34.47B | 36.69%17.74B | -13.76%26.6B | 3.23%12.98B | -6.05%30.85B | -39.25%12.57B | 1.78%32.83B | 18.03%20.7B | 48.14%32.26B |
Refund | -17.15%-12.64B | -14.50%-24.38B | 6.70%-10.79B | 3.79%-21.3B | 24.54%-11.56B | 21.53%-22.14B | -30.40%-15.32B | -27.26%-28.21B | -7.06%-11.75B | -147.38%-22.17B |
Issuance of bonds | --3.17B | -16.58%3.43B | ---- | -40.50%4.11B | -43.17%2.89B | 146.66%6.91B | --5.09B | -27.72%2.8B | ---- | 0.41%3.88B |
Dividends paid - financing | ---- | -14.60%-2.65B | ---- | -17.54%-2.31B | ---- | -17.91%-1.96B | ---- | -16.68%-1.67B | ---- | 19.70%-1.43B |
Absorb investment income | ---- | 165.26%205.36M | ---- | -81.51%77.42M | ---- | 42.89%418.75M | ---- | 44.74%293.07M | ---- | -40.79%202.48M |
Issuance expenses and redemption of securities expenses | ---1.09B | 34.82%-2.8B | ---- | -8.48%-4.29B | ---- | ---3.95B | ---- | ---- | ---- | ---- |
Other items of the financing business | -8.33%-1.89B | -8.08%-3.6B | -7.71%-1.74B | -7.35%-3.33B | -19.16%-1.62B | 0.79%-3.1B | 5.51%-1.36B | -42.03%-3.13B | -38.04%-1.44B | -25.19%-2.2B |
Net cash from financing operations | 10.84%5.78B | 963.04%4.55B | 93.66%5.21B | -107.57%-527.02M | 173.87%2.69B | 141.69%6.96B | -86.92%982.45M | -72.58%2.88B | 36.06%7.51B | 9.66%10.51B |
Effect of rate | 52.32%-491.62M | -30.05%-1.33B | 8.49%-1.03B | -325.85%-1.02B | -1,276.66%-1.13B | -60.10%453.67M | 149.88%95.75M | 3,252.44%1.14B | -264.19%-191.97M | 89.67%-36.07M |
Net Cash | -35.28%4.19B | 3,246.69%6.22B | 38.02%6.47B | -87.39%185.94M | 311.99%4.69B | 211.22%1.47B | -301.39%-2.21B | -128.14%-1.33B | -65.22%1.1B | 570.73%4.71B |
Begining period cash | 20.81%28.39B | -3.45%23.5B | -3.45%23.5B | 8.60%24.34B | 8.60%24.34B | -0.83%22.41B | -0.83%22.41B | 26.09%22.6B | 26.09%22.6B | 2.01%17.92B |
Cash at the end | 10.87%32.09B | 20.81%28.39B | 3.73%28.94B | -3.45%23.5B | 37.50%27.9B | 8.60%24.34B | -13.67%20.29B | -0.83%22.41B | 11.78%23.51B | 26.09%22.6B |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.